{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:40:43Z","timestamp":1793500843545,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T00:00:00Z","timestamp":1494892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.drugalcdep.2017.01.048","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T14:46:35Z","timestamp":1495032395000},"page":"133-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"special_numbering":"C","title":["The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting"],"prefix":"10.1016","volume":"176","author":[{"given":"Joseph K.","family":"Eibl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Daiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Varenbut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Hogenbirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1755-6481","authenticated-orcid":false,"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2005.05.010","article-title":"Cycling in and out of treatment; participation in methadone treatment in NSW, 1990\u20132002","volume":"81","author":"Bell","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/tmj.2012.0299","article-title":"The Ontario telemedicine network: a case report","volume":"19","author":"Brown","year":"2013","journal-title":"Telemed. J. e-Health"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0020","series-title":"Do You Know\u2026Methadone","author":"CAMH","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0025","series-title":"Methadone Maintenance Treatment Program Standards and Clinical Guidelines M. Program, Ed.","author":"CPSO","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Tech. Assess."},{"issue":"Suppl. 5","key":"10.1016\/j.drugalcdep.2017.01.048_bib0035","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1086\/421404","article-title":"Directly observed therapy for the management of HIV-infected patients in a methadone program","volume":"38","author":"Conway","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ADM.0000000000000156","article-title":"Evaluating the effectiveness of first-time methadone maintenance therapy across northern, rural, and urban regions of Ontario, Canada","volume":"9","author":"Eibl","year":"2015","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0050","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/add.12863","article-title":"Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006\u20132010","volume":"110","author":"Evans","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0055","first-page":"e13","article-title":"Trends in opioid use and dosing among socio-economically disadvantaged patients","volume":"5","author":"Gomes","year":"2011","journal-title":"Open Med."},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0060","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/add.12598","article-title":"The burden of premature opioid-related mortality","volume":"109","author":"Gomes","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0065","series-title":"Best Practices: Methadone Maintenance Treatment, Publications, Ed.","author":"Health-Canada","year":"2002"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0070","first-page":"2193","article-title":"Facilitating medical withdrawal from opiates in rural Ontario","volume":"12","author":"Kiepek","year":"2012","journal-title":"Rural Remote Health"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/08897077.2015.1129388","article-title":"Project ECHO (Extension for Community Healthcare Outcomes): a new model for educating primary care providers about treatment of substance use disorders","volume":"37","author":"Komaromy","year":"2016","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0080","series-title":"Measuring Rurality \u2013 RIO2008_BASIC: Methodology and Results, O. E. Department, Ed.","author":"Kralj","year":"2009"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0085","first-page":"e1","article-title":"Building access to specialist care through e-consultation","volume":"7","author":"Liddy","year":"2013","journal-title":"Open Med."},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1715163512473928","article-title":"Ontario pharmacists concerned about the risks arising from approval of generic OxyContin","volume":"146","author":"Lynas","year":"2013","journal-title":"Can. Pharm. J. (Ott.)"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0095","first-page":"204","article-title":"Ontario police chiefs call on the federal government to keep generic OxyContin out of Canada","volume":"145","author":"Lynas","year":"2013","journal-title":"Can. Pharm. J. (Ott.)"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0100","doi-asserted-by":"crossref","first-page":"E893","DOI":"10.1503\/cmaj.109-4326","article-title":"Feds must step up and restrict generic oxycodone, Ontario says","volume":"184","author":"Miller","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/aje\/kwp186","article-title":"Proportional hazards frailty models for recurrent methadone maintenance treatment","volume":"170","author":"Nosyk","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsat.2010.03.008","article-title":"Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996\u20132006","volume":"39","author":"Nosyk","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0115","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1360-0443.2012.03870.x","article-title":"Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study","volume":"107","author":"Nosyk","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/tmj.2015.0133","article-title":"Driving distance to telemedicine units in northern Ontario as a measure of potential access to healthcare","volume":"22","author":"O'Gorman","year":"2015","journal-title":"Telemed. J. e-Health"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/tmj.2015.0166","article-title":"Clinical telemedicine utilization in Ontario over the Ontario telemedicine network","volume":"22","author":"O'Gorman","year":"2016","journal-title":"Telemed. J. e-Health"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00952990.2012.741167","article-title":"Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand?","volume":"39","author":"Oliva","year":"2013","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0135","series-title":"How the Epidemic of Drug Overdose Deaths Ripples Across America","author":"Park","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2009.09.013","article-title":"15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel","volume":"107","author":"Peles","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0145","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s10461-013-0584-z","article-title":"Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users","volume":"18","author":"Reddon","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/11597520-000000000-00000","article-title":"Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals","volume":"72","author":"Tetrault","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0155","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2013tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0160","first-page":"1591","article-title":"A closer look at Ontario's northern and southern rural physician demographics","volume":"11","author":"Wenghofer","year":"2011","journal-title":"Rural Remote Health"},{"key":"10.1016\/j.drugalcdep.2017.01.048_bib0165","series-title":"WHO Model List of Essential Medicines","author":"World Health Organization","year":"2013"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T15:20:13Z","timestamp":1535815213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617302077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":33,"alternative-id":["S0376871617302077"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.01.048","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.01.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}